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Abstract
Background: The health and economic impact of mental and behavioural disorders (MBD) is
wide-ranging, long-lasting and large. Unfortunately, unlike in developed countries where studies on
the economic burden of MBD exist, there is a dearth of such studies in the African Region of the
World Health Organization. Yet, a great need for such information exists for use in sensitizing
policy-makers in governments and civil society about the magnitude and complexity of the
economic burden of MBD. The purpose of this study was to answer the following question: From
the societal perspective (specifically the families and the Ministry of Health), what is the total cost
of MBD patients admitted to various public hospitals in Kenya?
Methods: Drawing information from various secondary sources, this study used standard cost-of-
illness methods to estimate: (a) the direct costs, i.e. those borne by the health care system and the
family in directly addressing the problem of MBD; and (b) the indirect costs, i.e. loss of productivity
caused by MBD, which is borne by the individual, the family or the employer. The study was based
on Kenyan public hospitals, either dedicated to care of MBD patients or with a MBD ward.
Results: The study revealed that: (i) in the financial year 1998/99, the Kenyan economy lost
approximately US$13,350,840 due to institutionalized MBD patients; (ii) the total economic cost
of MBD per admission was US$2,351; (iii) the unit cost of operating and organizing psychiatric
services per admission was US$1,848; (iv) the out-of-pocket expenses borne by patients and their
families per admission was US$51; and (v) the productivity loss per admission was US$453.
Conclusions: There is an urgent need for research in all African countries to determine: national-
level epidemiological burden of MBD, measured in terms of the prevalence, incidence, mortality,
and, probably, the disability-adjusted life-years lost; and the economic burden of MBD, broken
down by different productive and social sectors and occupations of patients and relatives.
Background
"..mental health affects all spheres of human endeavour and
that there is no health without mental health. .. Ministers (of
Health at the 54th World Health Assembly) agreed that rais-
ing the level of awareness is the first priority. Policy-makers in
government and civil society need to be sensitized about the
huge and complex nature of the economic burden of MBD and
the need for more resources to treat MBD."
Senator the Hon. Phillip C. Goddard, Minister of Health,
Barbados [1].
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The historical marginalization of mental health from
mainstream health and welfare services in many countries
has contributed to endemic stigmatization and discrimi-
nation of MBD people [2]. As a result, mental health has
received low priority in health policy development, health
services, psychiatric human resource development and
resource allocation. Yet, worldwide, mental and neurolog-
ical conditions account for a substantive proportion of the
global burden of disease. For example, in 1999, neuropsy-
chiatric disorders resulted in 911,000 deaths and a loss of
158.7 million disability-adjusted life-years (DALYs)
among the 191 WHO Member States [3]. Approximately,
9% of those deaths and 10% of the lost DALYs occurred
in the WHO's African Region. Of the latter DALY losses,
35.5% were attributed to unipolar major depression,
10.2% to bipolar affective disorder, 3.5% to psychoses,
11.6% to epilepsy, 13.2% to alcohol dependence, 2.3% to
Alzheimer's disease and other dementia, 0.5% to Parkin-
son's disease, 0.7% to multiple sclerosis, 2.8% to drug
dependence, 1.5% to post-traumatic stress disorder, 7.3%
to obsessive-compulsive disorders, 3.4% to panic disorder
and 7.6% to other neuropsychiatric disorders.
Groups at a higher risk of developing mental and behav-
ioural disorders (MBD) include people with serious or
chronic physical illnesses, children and adolescents with
disrupted upbringing, people living in poverty or difficult
conditions, the unemployed, female victims of violence
and abuse, and the neglected elderly persons [2]. To these
we would add victims of natural (e.g. floods) and man-
made (e.g. civil wars) disasters, and those whose human
rights are recurrently violated.
The economic impact of MBD is wide-ranging, long-last-
ing and large [2]. It includes: the cost of organizing and
operating mental health-related services; the impact on
the families' and care-givers' resources; the expenses
related to crimes caused by the MBD; the productivity
losses due to debility, morbidity and premature death;
and the psychological pain borne by the patients and their
family members. A number of researchers, mainly from
developed countries, have estimated the aggregate eco-
nomic costs of MBD. Osterhaus et al. [4] estimated that
mental disorders costed the USA about US$42.3 billion in
1990. Rice et al. [5] estimated that mental disorders
accounted for approximately 2.5% of the gross national
product per year in USA. Meerding et al. [6] estimated that
23.2% of total annual health service expenditure in Neth-
erlands goes to the treatment of mental disorders. Patel
and Knapp [7] estimated that inpatient treatment of men-
tal disorders accounts for 22% of the annual national
health service expenditure in UK. Unfortunately, unlike in
North America and Europe, there is a dearth of studies
that have attempted to estimate the economic burden of
MBD in the African Region [8].
This article focusses on the economic burden of MBD. It
attempts to answer the question: From the societal per-
spective (specifically the families and the Ministry of
Health), what is the total cost of MBD patients admitted
to various public hospitals in Kenya? The specific objec-
tives were to estimate: (a) the direct costs, i.e. those borne
by the health-care services and the families in directly
addressing the problem; and (b) the indirect costs, i.e.
mainly the losses in productivity caused by the disease,
borne by the individual, the family or the employer.
Methods
Study site
Like elsewhere in the African Region where the prevalence
and extent of poverty is high, MBD is a major public
health problem in Kenya. It is estimated that over 30% of
the people attending health facilities in the country suffer
from some form of MBD, with many of them going largely
unrecognized and receiving inappropriate treatment [9].
A majority of MBD patients are treated at the Mathare Psy-
chiatric Hospital and in general hospitals with psychiatric
wards, e.g. in Kakamega, Nakuru, Murang'a, Nyeri, Mach-
akos, Mombasa, Kisumu, Eldoret and Gilgil. The Mathare
Hospital is the largest psychiatric facility in the country
with 1,043 beds, of which 61% are general care beds and
39% maximum security beds. In 1999, a total of 5,678
inpatients (49% of whom were female) were treated at the
aforementioned hospitals. About 24% of them were hos-
pitalized at the Mathare Psychiatric Hospital; 42%, 52%
and 6% of the patients fell within the age brackets of 10–
25 years, 25–49 years and 50 years and above respectively.
Nearly 4.5% of the patients died during treatment [10].
The estimates of the economic burden reported in this
study are based on the 5,678 inpatient cases of MBD.
Conceptual framework
Definition of costs estimated
The economic burden of MBD comprises direct costs,
indirect costs and intangible costs. Direct costs has two
strands. Firstly, the costs to the government of organizing
and operating psychiatric hospital services: personnel
remunerations (including salaries and fringe benefits);
travel; transport operations; materials (e.g. consumable
materials, uniforms, hospital linen, stationery, medical
records); drugs; non-pharmaceutical supplies (e.g. dress-
ings and other disposable inputs); administration
(including expenses of boards, committees and confer-
ences); utilities (i.e. electricity, water, telephone, postage
and conservancy); kitchen (including food and gas
expenses); diagnostics (clinical laboratory and imagery);
maintenance (of vehicles, equipment and buildings);
rents and rates; and capital costs (i.e. purchase of vehicles,
beds, equipment and buildings) [11]. The capital items
were annuitized assuming a useful life span of 30 years for
buildings, 10 years for equipment and vehicles [12]. AAnnals of General Hospital Psychiatry 2003, 2 http://www.general-hospital-psychiatry.com/content/2/1/7
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10% discount rate was used to annuitize capital costs. It is
the rate that has been used in other costing studies under-
taken in Kenya [12,13]. Thus, the annual equivalent costs
for buildings, equipment and vehicles were obtained by
dividing their replacement values by the appropriate
annuity factors. Secondly, the out-of-pocket expenses
borne by the patients and their families, including: return-
journey bus fare for patients, accompanying persons and
visitors; lunch and dinner expenses when visiting patients;
accommodation expenses during visits; user fees for treat-
ment; X-ray fees; laboratory tests fees; official mortuary
fees and informal mortuary attendants' payments (for
patients who die during treatment); and funeral expenses,
e.g. transportation of bodies and the accompanying peo-
ple [14].
The indirect costs consist of opportunity cost of time lost
due to morbidity and premature mortality. The morbid-
ity-related component includes the productivity losses of
time invested by patients in pre-admission consultations,
travel to and from hospitals, waiting for admission, and
during institutionalized treatment; by relatives accompa-
nying patients during pre-admission consultations, travel
to and from hospitals accompanying patient(s), waiting
for patients to be admitted, and visiting patients after
admission. The confirmatory diagnostic tests are per-
formed after admission. Thus, the diagnostic, treatment,
side-effects monitoring and treatment times are all cap-
tured within the duration of stay [14].
The premature mortality-related cost component is equal
to the lost work-years due to premature death (i.e.
national retirement age minus age at death) times average
remuneration per year. A casual labour wage rate of
US$1.00 per day (which is also equivalent to the interna-
tional poverty line) was used for valuing all the lost labour
time.
Intangible costs refer to welfare losses due to the physical
and psychological pain. Due to the stigma attached to
MBD, the related psychic and social costs to the affected
families can be profound. For example, in most Kenyan
communities, most people are very reluctant to marry into
families with a history of MBD. As a result, many young
men and women from families with a history of MBD
often find it difficult to get marriage partners. Time con-
straints prohibited the collection of willingness-to-pay
data that would have facilitated the estimation of intangi-
ble costs.
Analytical model
The total economic cost (TEC) incurred by MBD patients
and relatives can be expressed as follows:
TEC = DC + IC + ITC ........................... (1)
where: DC is direct cost, IC is indirect cost (which is pro-
ductivity loss) and ITC is intangible cost (including phys-
ical and psychological pain).
The total direct cost (DC) was estimated using equations
2 to 10:
DC = COO + OoPE ................................ (2)
where: COO are the total costs borne by government in
operating and organizing mental hospital services; and
OoPE are the out-of-pocket expenses borne by patients,
family members and relatives.
COO = P + FB + TOE + TE + U + BCC + DR + FO + NP +
MA + ME + RR + KC .............................. (3)
where: P is personnel remunerations; FB is fringe benefits;
TOE is transport operating expense; TE is travel expense; U
is cost of utilities; BCC is the expense of hospital boards,
committees and conferences; DR is the cost of drugs; FO
is the cost of food and cooking gas; NP is the cost of non-
pharmaceutical supplies; MA is the cost of materials; ME
is the cost of vehicles, equipment and building mainte-
nance; RR is the rent and rates; and KC is the annual
equivalent cost of capital items. The raw data for COO
components was obtained from the Government of Kenya
[11] recurrent and development expenditure estimates.
OoPE = L + D + A + F + UF + OF ............... (4)
where: L is lunch cost during visits, D is visitors' dinner
cost, A is visitors' accommodation cost, F is travel cost
(bus fare), UF is the average user fees, and OF is other fees;
L = NA × NL × NVs × CL ............................... (5)
where: NA is the number of admissions, NL is the number
of lunches per trip, NVs is the number of visits, and CL is
the average cost per lunch;
D = NA × ND × NVs × CD ............................ (6)
where: ND is the number of dinners per trip, NVs is the
number of visits, and CD is the average cost per dinner;
A = NA × NV × NVs × NN × CN ....................(7)
where: NV is the number of visitors, NN is the number of
nights spent in a town where a hospital is situated, and
CN is the average cost per night;
F = NA × NV × NVs × CF ...............................(8)
where: CF is the average return fare per person per visit;Annals of General Hospital Psychiatry 2003, 2 http://www.general-hospital-psychiatry.com/content/2/1/7
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UF = NA × ALS × UFPD ...............................(9)
where: ALS is the average length of hospitalization in days
and UFPD is the average user fees per day; and
OF = NA × OFALS ...........................................(10)
where: OFALS is the other fees per average length of stay.
The total indirect costs (IC) were obtained using the fol-
lowing algorithm:
IC = LH + LV .................................................. (11)
where: LH are the productivity losses due to work days lost
by patients and LV is the productivity loss due to the work-
time lost by relatives accompanying and visiting patients;
LH = NA × ALOS × WR ....................... (13)
where: WR is the wage rate per hour or day; and
LV = NA × NV × NVs × TV × WR .......... (14)
where: TV is the time spent by a visitor per visit. This
includes the time spent travelling, waiting and socializing
with a patient at a hospital.
The total intangible costs (ITC) were not estimated in this
study. The estimations for out-of-pocket expenses and
productivity losses incurred by patients and their families
were based on two sets of assumptions: first, those related
to patients from within the district where the hospital is
situated; and second, those related to patients admitted
from other districts. Both sets of assumptions are con-
tained in the Appendix. Those assumptions are based on
past Kenyan health facility-based studies [9,14].
Limitations of the study
(a) Omission of intangible costs
Due to research resource constraints, data used in this
study were obtained mainly from secondary sources.
Thus, it was not possible to collect willingness-to-pay data
that would have facilitated the estimation of intangible
costs, i.e. the costs of physical and psychological pain and
loss of leisure time. However, they can potentially be esti-
mated using the following algorithm:
ITC = NA × WTP ................................(15)
where: NA is as defined previously and WTP is the average
amount of money (or its equivalent in goods or services)
that each patient's family would be willing to pay for an
intervention that would obviate any form of MBD, and
hence the associated stigma and pain. Readers who are
interested in knowing how to elicit WTP values in an Afri-
can context can refer to Kirigia, Sambo and Kainyu [15].
(b) Use of casual-labour wage rate to value lost labour time
A casual-labour wage rate of US$1.00 per day was used in
valuing all the lost labour time. This may have led to an
underestimation of the economic burden since the
patients admitted in various hospitals were likely to have
belonged to a wide range of occupations, e.g. peasant
farmers, civil servants, private sector employees, self-
employed (business people), housewives, students,
unemployed, etc. However, the extremes may have been
modified by the fact that we did not adjust the estimated
figures by the rate of unemployment. We were reluctant to
make the adjustment since even those who were voluntar-
ily unemployed attached a lot of value to their leisure
time. In fact, economists have suggested that it would take
double the normal wage rate to induce such people to
trade off their leisure for paid work.
(c) Omission of economic burden imposed by non-institutionalized 
MBD patients
Although the current study focussed mainly on an estima-
tion of the economic burden emanating from the institu-
tionalized MBD patients, the same methodology could be
extended to non-institutionalized patients.
The cost of labour time lost per occupational category per
year will be equal to the days of work lost in a typical
month due to MBD, plus the days worked in a typical
month with MBD symptoms, times the per cent produc-
tivity on the days worked with MBD symptoms (assuming
normal productivity is 100%), times the daily earnings for
an individual within an occupational category (4,16).
Algebraically, this can be expressed as follows:
LTC = [MD + (DWS × PRO)] × WR × MO ............... (16)
where: LTC is the cost of the labour time lost by outpatient
MBD patients; MD is the number of the days of work
missed in a typical month due to MBD; DWS is the
number of the days worked in a typical month with MBD
symptoms; PRO is the productivity loss, i.e. 100% minus
the per cent productivity on the days worked with MBD
symptoms; WR is the average daily earnings for an indi-
vidual within an occupational category; and MO is 12
months per year.
(d) Omission of economic costs incurred by MBD patients seeking 
care among traditional medicine practitioners
MBD occurrence in the African Region is commonly asso-
ciated with local cultural values and various beliefs
(including religion, magic, ancestral spirits). In this con-
text, majority (although the exact number is unknown) of
MBD patients, particularly in rural areas, seek care fromAnnals of General Hospital Psychiatry 2003, 2 http://www.general-hospital-psychiatry.com/content/2/1/7
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traditional medicine practitioners, e.g. traditional 'priests'
(diviners and rainmakers), herbalists, magicians, sorcer-
ers. Usually, such patients, majority of whom are poor,
pay the cost of treatment in-kind, e.g. chicken, goats, cere-
als. This study did not estimate the economic cost
incurred by MBD patients that sought care among tradi-
tional medical practitioners.
Results
Table 1 provides an itemized schedule of various costs of
operating and organizing (COO) hospital psychiatric
services during the Kenya Government's financial year
1998/99. The COO amounted to US$10,491,275, out of
which 82.3% constituted recurrent costs and 17.7% capi-
tal costs. Personnel-related expenses, drugs, kitchen (food
and gas), and utilities accounted for 61%, 5%, 7% and 3%
respectively.
Table 2 presents a summary of the direct and indirect
costs. The cost of operating and organizing inpatient psy-
chiatric services in public hospitals amounted to US$10.5
million per year.
The total out-of-pocket expenses (OoPE) borne by
patients and their relatives was US$289,846.
The indirect costs (IC) added up to US$2,569,719.
Ninety-two per cent of the total productivity losses were
attributed to premature mortality and 8% to the time lost
through hospitalization of MBD patients.
The grand total economic loss (i.e. COO plus IC) attribut-
able to the 5,678 admissions due to MBD at various pub-
lic hospitals in Kenya was US$13,350,840.
Discussion
The key findings of this study were:
• The unit cost of operating and organizing psychiatric
services (COO) per admission was US$1848 (i.e.
US$10,491,275 divided by 5,678 inpatients).
• The out-of-pocket expenses (OoPE) borne by patients
and their relatives per admission were US$51 (i.e.
US$289,846 divided by 5,678 inpatients).
• The productivity loss per admission was US$453 (i.e.
US$2,569,719 divided by 5,678 inpatients).
• The direct and indirect costs constituted 81% and 19%
of the total economic burden of MBD.
• The total economic cost of MBD per admission was
US$2,351 (i.e. US$13,350,840 divided by 5,678
inpatients).
The grand total economic cost attributable to the 5,678
MBD admissions at various Kenyan hospitals constituted
approximately 10% of the Ministry of Health's total recur-
rent expenditure in 1998/99. This is an enormous loss in
a country where 50% of the population live on less than
US$1 per day and 56% of the population have no access
to safe drinking water and 15% have no access to ade-
quate sanitation facilities (17).
The readers will recall that 23.2% of total annual health
service expenditure in Netherlands [6]; and 22% of the
annual national health service expenditure in UK [7] goes
to the treatment of mental disorders. Thus, in comparative
terms, the Kenyan estimate of 10% of the Ministry of
Health budget is lower than that of the Netherlands and
Table 1: Annual cost of operating and organizing psychiatric services in Kenya (1 US$ = Ksh. 65 in 1998/99)
Cost items Cost (US$) Percentage
Personnel salaries 4,837,527 46.11
Fringe benefits 1,569,495 14.96
Transport operating expenses 39,867 0.38
Travel expenses 26,228 0.25
Utilities 281,166 2.68
Hospital boards, committees & conferences 17,835 0.17
Drugs 568,627 5.42
Food & cooking gas 750,126 7.15
Non-pharmaceutical supplies 118,551 1.13
Materials 257,036 2.45
Maintenance 91,274 0.87
Rents and rates 77,635 0.74
Annual capital cost 1,855,907 17.69
TOTAL COST 10,491,275 100Annals of General Hospital Psychiatry 2003, 2 http://www.general-hospital-psychiatry.com/content/2/1/7
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the UK. This difference could be attributed to two factors.
Firstly, there is evidence that many of MBD patients in
Kenya go largely unrecognized and/or wrongly diagnosed
and receiving inappropriate treatment in the non-psychi-
atric health facilities [9]. Secondly, the current study omit-
ted the economic burden imposed by non-
institutionalized MBD patients who are treated in health
centres, public hospitals outpatient departments, profit
and not-for-profit private hospitals and traditional medi-
cal practitioners clinics.
Conclusion
This study, in spite of its limited scope, has demonstrated
that MBD imposes a substantive economic cost on the
country. And, although the current study focussed mainly
on an estimation of the economic burden emanating
from the institutionalized MBD patients, it has demon-
strated how the same methodology could be extended to
non-institutionalized patients.
Given the high degree of ignorance about the magnitude
of the epidemiological and economic burdens of MBD in
sub-Saharan Africa, there is an urgent need for research to
determine:
• national-level epidemiological burden of MBD, meas-
ured in terms of its prevalence, incidence, mortality and,
probably, disability-adjusted life-years lost;
• national-level economic burden of MBD, broken down
by different productive and social sectors and occupations
of patients and relatives; and
• costs and consequences of alternative treatments, pre-
vention of MBD and promotion of mental health to facil-
itate use of more cost-effective strategies and informed
choice of interventions.
• proportion of MBD patients seeking care from tradi-
tional medicine practitioners and the reasons for such a
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Appendix: assumptions
The assumptions presented below are based on studies
undertaken in Kenya [9,14].
Assumptions related to patients from within the district where
the hospital is situated:
A. 60% of inpatient admissions are from the district where
a hospital is situated;
B. each patient is accompanied by two adults when being
taken for admission;
C. each patient will, on average, spend 29.9 days in the
hospital;
D. each patient and the two accompanying adults will
spend a total of 8 hours each, i.e. including seeking
doctor's/magistrate's recommendation for admission,
travel time and waiting for admission. During the visit a
total of US$9 will be spent on lunch (i.e. US$3 per
person);
E. each patient will have a one-day visit by two relatives /
friends during the length of his/her stay. During the visit
a total of US$9 will be spent on lunch (i.e. US$3 per
person);
F. return journey public transport fare is US$0.77 per per-
son; and
Table 2: Direct and indirect costs of MBD (1 US$ = Ksh. 65 in 1998/99)
Cost components Cost (US$) Percentage
Direct costs:
(1). Total cost of operating and organizing psychiatric services 10,491,275 78.6
(2) Out-of-pocket expenses borne by patients and family members 289,846 2.2
Indirect costs:
(1) Value of productivity lost by patients and family members due to MBD morbidity 203,840 1.5
(2) Value of productivity lost through premature mortality of MBD patients 2,365,879 17.7
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G. wage rate per hour is US$0.125 per hour.
Assumptions related to patients admitted from other districts:
A. 40% of inpatient admissions are from other districts;
B. each patient is accompanied by two adults when being
taken for admission;
C. each patient will, on average, spend 29.9 days in the
hospital;
D. each patient and the two accompanying adults will
spend a total of 16 hours each, i.e. including seeking doc-
tor's/magistrate's recommendation for admission, travel
time and waiting for admission;
E. the two accompanying relatives will spend a night in
the town where the hospital is located. Thus, each will
incur a hotel accommodation and breakfast cost of US$8,
lunch cost of US$3, and dinner cost of US$3;
F. each patient will have a one-day visit by two relatives /
friends during the length of his/her stay;
G. return journey public transport fare is US$7.7 per per-
son; and
H. wage rate per hour is US$0.125 per hour.
Assumption related to the MBD patients
We are assuming that all the 5678 cases reported in this
study fall within the mental and behavioural disorders
defined in ICD10 [18].
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